• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Goldman Sachs spinoff Juven to back African high-growth companies with large checks

October 6, 2021 by David Barret Leave a Comment

Mauritius and U.K.-based investment company Juven went live today with plans to fund growth-stage technology and consumer companies in Africa.

The one-year-old firm is looking to invest large checks in companies “that have proven business models, strong revenue traction and large addressable markets,” it said in a statement.

Juven is one of the few investment firms targeting growth deals on the continent, including TLcom, Novastar and Partech Africa, that have written significant checks in tech companies in recent years. 

But unlike the others, Juven is not a venture capital fund; the evergreen investment company is a spinoff from Goldman Sachs’ Africa principal team responsible for making several high-growth investments in the tech scene since 2014.

Juven founder Jules Frebault led this team (also known as the Special Situations Group). He joined Goldman Sachs in 2010 and grew out the department’s strategy from a Johannesburg office to back companies that could make good returns on the continent.

The team first made some investments across private equity and credit; the most notable bets were in telecom-led businesses and towers like the IHS Towers.

Down the line, Goldman Sachs dipped its hand into growth-stage investing in tech companies, backing Africa’s first unicorn Jumia, Zipline, and Eat’N’Go. It also led investments in Unicaf’s Series B round, Jumo’s second Series B, Kobo360’s Series A, and Twiga Foods’ Series B round.

South African fintech startup Jumo raises second $50M+ VC round

Frebault tells TechCrunch that the Juven team spun out off Goldman Sachs to “go after the growth-stage opportunity in Africa with a dedicated structure, capital, resources and mandate.”

Thus, Goldman Sachs transferred its growth portfolio — Unicaf, Jumo, Kobo360, Twiga, and Eat’N’Go — to Juven. Some former Goldman Sachs employees also left with Frebault to build out Juven’s operations.

The firm is structured to have a holding company and a balance sheet that holds its assets in cash. This way, when an investment is monetized, the capital comes back and Juven redeploys it. Such methods allow for making multiple investments without raising a dedicated fund.

“It’s actually akin to a corporate in terms of how it’s structured,” Frebault said. “And the capital that we deploy either comes from our balance sheet or we take on follow-on investments from our shareholders.” 

In that light, Juven has re-invested in four companies in its current portfolio this year. Though it plans to add more investments before the next year runs out, Frebault says the firm might not make more than three investments per year.

The average ticket size will range from $10 million to $30 million, then $50 million or more in follow-on checks. The founder says that for tech companies, which is one of Juven’s primary targets, it targets Series B and later-stage growth rounds.

Since Juven makes only a handful of investments per year, the firm will provide additional benefits around financial, legal, operational and strategic support.

“We have to be flexible and start at $10 million because it can be the right size for Series B rounds on the continent,” Frebault said. “We don’t take a venture capital approach, and we don’t invest in many companies. We take concentrated positions and then continue investing in these companies over time.”

Juven’s focus is on entrepreneurs trying to leverage tech to solve problems around access for the masses, the company said. Frebault adds that Juven may also consider non-tech companies that can solve such problems.

Although the firm says it can invest in almost anything, businesses solving problems around food, education, healthcare, financial services, commerce and logistics will most likely get a nod before others.

“We can invest in everything but we’re staying away from is extractive industries,” the founder said.

It’s the same situation with countries as the investment firm has a preference for businesses expanding regionally in large consumer economies like Nigeria, Kenya, Egypt, South Africa, Ghana and the Ivory Coast.

Even though the team that led Goldman Sachs’ investments in Africa is now at Juven, Frebault says the 152-year-old investment giant’s Asset Management division still has a global mandate that includes Africa, albeit focusing on a much larger scale and institutional activity.

Goldman Sachs declined to comment on Frebault’s move, Juven’s activity, its own broader objectives or plans for the region in the future.

What we know (and don’t) about Goldman Sachs’ Africa VC investing

Source Link Goldman Sachs spinoff Juven to back African high-growth companies with large checks

David Barret
David Barret

Related posts:

  1. Apple M1X MacBook Pro might drop as early as October
  2. Monte dei Paschi prepares to close 50 branches – letter to unions
  3. Billions blown as Macau casino investors fold amid gambling review
  4. Cyclone Shaheen approaches Oman, flights delayed

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The Invisible World Around Us: How Can We Capture And Clean The Air We Breathe?
  • 85-Million-Year-Old Dinosaur Eggs Dated Using “Atomic Clock For Fossils” For The First Time
  • Why Shouldn’t You Kiss Babies? New Study Shows Even Healthy Newborns Can Become Severely Ill With RSV
  • Earth Has A New Quasi-Moon – And It Has Probably Been Around For Decades
  • Want To Kill Your Prey? Do It Feather-Legged Lace Weaver Spider Style And Vomit All Over Them
  • IFLScience The Big Questions: Are We In The Anthropocene?
  • The Wildfire Paradox Affecting 440 Million People Has As Worrying A Solution As You’d Expect
  • AI May Infringe On Your Rights And Insult Your Dignity (Unless We Do Something Soon)
  • How Do You Study Cryptic Species? We’re Finally Lifting The Lid On The World’s Least Understood Mammals
  • Once-In-A-Decade Close Encounter With Hazardous Asteroid 2025 FA22 Approaches
  • With 229 Pairs, This Beautiful Animal Has The Highest Number Of Chromosomes Of Any Animal
  • “An Unimaginable Breakthrough”: Loudest-Ever Gravitational Wave Collision Proves Stephen Hawking Correct
  • Exciting Martian Mudstone Has Features That Might Be Considered Biosignatures
  • How Long Did Dinosaurs Live? “It’s A Big Surprise To People That Work On Them”
  • NASA’s Mysterious Announcement: “Clearest Sign Of Life That We’ve Ever Found On Mars”
  • New Brain Implant Can Decode Your Internal Monologue, Raising Fears Of Mind Reading
  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • How Does 2-In-1 Shampoo And Conditioner Work?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version